iRhythm Holdings, Inc. (IRTC): Cost of Revenue
$219.89M
Year ended 2025-12-31
$235.60M
Trailing 12 months to 2026-06-30
+19.4%
3-year compound annual growth
+25.6%
5-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $219.89M | +19.3% | 2026-02-19, From 2025-01-01 |
| 2024-12-31 | $184.31M | +14.6% | 2026-02-19, From 2024-01-01 |
| 2023-12-31 | $160.88M | +24.4% | 2026-02-19, From 2023-01-01 |
| 2022-12-31 | $129.29M | +18.3% | 2025-02-20, From 2022-01-01 |
| 2021-12-31 | $109.26M | +55.5% | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | $70.28M | +33.9% | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | $52.48M | +35.3% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | $38.80M | +37.6% | 2021-02-26, From 2018-01-01 |
| 2017-12-31 | $28.20M | n/c | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | $20.88M | +42.1% | 2019-03-04, From 2016-01-01 |
| 2015-12-31 | $14.70M | +38.8% | 2018-03-01, From 2015-01-01 |
| 2014-12-31 | $10.59M | n/a | 2017-03-31, From 2014-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | 2025-12-31 | $219.89M | +19.3% |
| Alphatec Holdings, Inc. (ATEC) | 2025-12-31 | $232.27M | +24.0% |
| Orthofix Medical Inc. (OFIX) | 2025-12-31 | $256.30M | +1.1% |
| NovoCure Ltd (NVCR) | 2025-12-31 | $166.88M | +21.6% |
| Inspire Medical Systems, Inc. (INSP) | 2025-12-31 | $133.22M | +8.3% |
| UFP Technologies Inc (UFPT) | 2025-12-31 | $432.39M | +20.9% |
| Bioventus Inc. (BVS) | 2025-12-31 | $179.93M | -2.8% |
| Tandem Diabetes Care Inc (TNDM) | 2025-12-31 | $468.72M | +4.0% |
| AtriCure, Inc. (ATRC) | 2025-12-31 | $133.75M | +13.6% |
Compare IRTC, ATEC, OFIX, NVCR side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗